The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; none of the 6 sources its claims cite is checked for support yet.
SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Open accessAbstract
The Sir2 deacetylase regulates chromatin silencing and lifespan in Saccharomyces cerevisiae. In mice, deficiency for the Sir2 family member SIRT6 leads to a shortened lifespan and a premature ageing-like phenotype. However, the molecular mechanisms of SIRT6 function are unclear. SIRT6 is a chromatin-associated protein, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown. Here we show that the human SIRT6 protein is an NAD+-dependent, histone H3 lysine 9 (H3K9) deacetylase that modulates telomeric chromatin. SIRT6 associates specifically with telomeres, and SIRT6 depletion leads to telomere dysfunction with end-to-end chromosomal fusions and premature cellular senescence. Moreover, SIRT6-depleted cells exhibit abnormal telomere structures that resemble defects observed in Werner syndrome, a premature ageing disorder. At telomeric chromatin, SIRT6 deacetylates H3K9 and is required for the stable association of WRN, the factor that is mutated in Werner syndrome. We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function. Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Human SIRT6 is an NAD+-dependent histone H3 lysine 9 (H3K9) deacetylase that associates with telomeres in S phase and maintains low H3K9 acetylation there. SIRT6 depletion causes telomere dysfunction, chromosomal end-to-end fusions, and premature cellular senescence, and impairs WRN association at telomeric chromatin, linking SIRT6 to telomere maintenance and Werner syndrome-like defects.
Key findings
- SIRT6 knockdown in WI-38 human fibroblasts shortened replicative lifespan, causing premature senescence about ten population doublings before controls, with increased senescence-associated β-galactosidase staining; two independent SIRT6 shRNAs reproduced this, while irrelevant shRNAs did not.
- SIRT6-depleted cells showed elevated telomere dysfunction-induced foci, non-recurrent chromosomal end-to-end fusions that were more pronounced at later population doublings, and Werner syndrome-like telomere abnormalities including sister telomere loss, telomere doublets, and weak or absent telomere signals at fusion sites; mean telomere length was not significantly reduced.
- SIRT6 deacetylated H3K9Ac specifically among tested acetylated histone peptides, with no deacetylation detected for 12 other acetylated histone peptides; the catalytic mutant H133Y markedly decreased activity. SIRT6 knockdown caused H3K9 hyperacetylation at telomeric chromatin in S phase, and S6KO mouse cells also showed telomeric H3K9 hyperacetylation.
- SIRT6 was required for stable WRN association at telomeric chromatin; SIRT6 knockdown significantly inhibited WRN association in U2OS and IMR90 cells. Telomerase expression reversed premature senescence, whereas augmenting base excision repair did not, and low oxygen culture did not prevent senescence.
Methods
- Retrovirus-mediated shRNA knockdown of SIRT6 in WI-38, IMR90, U2OS, and HeLa cells, with replicative senescence assays, SA-β-gal staining, immuno-FISH TIF assays, metaphase cytogenetics/SKY/telomere FISH, and cell-cycle flow cytometry.
- Telomere chromatin immunoprecipitation (T-ChIP) after thymidine synchronization and release, using antibodies against SIRT6, Flag, WRN, and H3K9Ac, with telomeric DNA detected by slot blot.
- In vitro histone deacetylation assays with recombinant SIRT6 and acetylated histone tail peptides or full-length histones, including mass spectrometry; 293T cells were transfected with wild-type or H133Y SIRT6 and analyzed by Western blotting.
Limitations
- Stated: SIRT6 showed only modest in vitro deacetylation activity on H3K9Ac peptides, and no direct SIRT6-WRN interaction at chromatin was observed, although additional functional or physical interactions might exist.
- Stated: S6KO mouse cells showed telomeric H3K9 hyperacetylation but did not display the downstream cellular defects seen in human cells, which the authors attribute to the large functional reserve of mouse telomeres.
- Evident: many conclusions rely on shRNA knockdown and overexpression in cultured cells, and several supporting results are reported as “data not shown”; global H3K9Ac levels did not differ significantly, so the key effect is telomere-specific.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
29 Own result · 23 Own interpretation · 3 Not checked yet · 1 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As controls, the association of Alu repeat sequences with SIRT6 ChIPs was not above background (Fig. 2b–d), and the SIRT6 T-ChIP signal was abolished in S6KD cells, validating the specificity of the signal (Fig. 2d).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In both U2OS and IMR90 cells, SIRT6 knockdown significantly inhibited the association of WRN with telomeric chromatin (Fig. 4a, b, and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, mean telomere length was not significantly reduced in S6KD cells (Supplementary Fig. 5).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of TIFs revealed elevated telomere dysfunction in S6KD cells (Fig. 1d, e, and Supplementary Fig. 4a).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, SIRT6 knockdown in U2OS cells resulted in delayed completion of S phase (Supplementary Fig. 14), which is consistent with a role for SIRT6 in modulating telomeres during replication.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, investigation of histone acetylation status at telomeres in S-phase-enriched cultures by T-ChIP revealed H3K9 hyperacetylation in S6KD cells (Fig. 3d–f).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 18
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Premature cellular senescence was also observed with two independent SIRT6 shRNAs, ruling out off-target shRNA effects, but not with irrelevant shRNAs (Supplementary Fig 2b–d and Supplementary Fig 3c).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 occupancy at telomeric chromatin was observed for both recombinant Flag-tagged SIRT6 (Fig. 2a, b) and endogenous SIRT6 (Fig. 2c, d), and in both U2OS osteosarcoma cells (Fig. 2b, c) and primary IMR90 cells (Fig. 2d).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This activity was highly specific for H3K9Ac, because no deacetylation was detected for 12 other acetylated histone peptides (Fig. 3a and Supplementary Fig. 11).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 also deacetylated H3K9Ac, but not several other acetylated residues, in the context of purified full-length histone H3, and mutation of a conserved catalytic residue (H133Y) of SIRT6 markedly decreased this activity (Fig. 3b and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 knockdown (S6KD) cells have a strikingly shortened replicative lifespan, undergoing premature cellular senescence about ten population doublings before control cells, and show increased levels of senescence-associated β-galactosidase (SA-β-gal) staining (Fig. 1b, c, and Supplementary Fig. 2a).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, SIRT6 efficiently and specifically deacetylated H3K9Ac (but not other acetylated histone residues) in 293T cells, whereas the mutant SIRT6 protein did not (Fig. 3c and Supplementary Fig. 12).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Non-recurrent chromosomal end-to-end fusions were observed in S6KD cells and were more pronounced at later population doublings, but they were rarely observed in control cells (Fig. 1f and Supplementary Fig. 4b, c).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, S6KD metaphases showed elevated levels of missing telomere signals (sister telomere loss) and extra telomere signals (telomere doublets) (Fig. 4d–f), defects observed in WS cells and associated with aberrant telomere processing during replication8,13,20.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations suggest that S6KD cells undergo accelerated senescence and telomere dysfunction in response to stochastic telomere sequence loss, without increased global telomere erosion.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We conclude that SIRT6 is crucial in maintaining a normal replicative life-span and in preventing the premature senescence of human cells.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these data locate SIRT6 at telomeric chromatin in S phase and suggest a potential role for SIRT6 in regulating replication-associated dynamics in telomere structure.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings suggest that SIRT6 collaborates with WRN at telomeric chromatin to ensure efficient telomere replication and to prevent the accrual of structural abnormalities at telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study has identified a crucial function for SIRT6 in chromatin regulation at mammalian telomeres and provides a new mechanism by which the regulation of chromatin is linked to telomere function, cellular senescence and, potentially, organismal ageing.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations indicate that SIRT6 is an NAD-dependent deacetylase with specificity for H3K9Ac.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose a model (Supplementary Fig. 1) in which the deacetylation of H3K9Ac by SIRT6 promotes the formation of a specialized telomeric chromatin state that is required for the stable association of S-phase-dependent telomere-processing factors such as WRN, to prevent aberrant sequence loss or metabolism of telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings demonstrate that telomere dysfunction, not BER defects or oxidative stress, underlie the premature senescence phenotype of S6KD cells.”
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
No enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.
“SIRT6 is a chromatin-associated protein3, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.”
“Although no physiological enzymatic activity for SIRT6 on histones or other trans substrate has yet been observed, we proposed that SIRT6 might regulate chromatin at telomeres by deacetylating a specific histone tail residue.”
The paper relies on this without support.
No effect of SIRT6 deficiency on cellular lifespan has been reported.
“Despite the ageing-like phenotype of SIRT6-deficient mice, no effect of SIRT6 deficiency on cellular lifespan has been reported.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SIRT6 promotes DNA double strand break repair19,20, regulates telomere stability21, suppresses inflammation22 and opposes tumorigenesis23,24.”
From SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age (2014) · cites this paper as [21]
In the citing paper
“In human cells, loss of SIRT6, an H3K9 deacetylase that silences telomeres, causes telomere dysfunction and premature cellular senescence (Michishita et al., 2008).”
From The Aging Epigenome (2016) · cites this paper as Michishita et al., 2008
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar‐Am, I., Soenksen, D. G., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,753
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6
Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., et al. (2006) · Cell · doi:10.1016/j.cell.2005.11.044 · Cited by 1,637
Self-citationDNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
Self-citationHerbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
Cited by
Sorted by citations
Items 701–800 of 998
Sirt6 is required for spermatogenesis in mice
Wei, H., Khawar, M. B., Tang, W., Wang, L., Wang, L., Liu, C., Jiang, H., & Li, W. (2020) · Aging · doi:10.18632/aging.103641 · Cited by 15
Toulassi, I. A., Saedi, U. A. A., Gutlapalli, S. D., Poudel, S., Kondapaneni, V., Zeb, M., & Cancarevic, I. (2021) · Cureus · doi:10.7759/cureus.12735 · Cited by 16
Kawakami, K., Nakamura, A., & Goto, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.120 · Cited by 15
Studies of the Binding of Modest Modulators of the Human Enzyme, Sirtuin 6, by STD NMR
Bolívar, B. E., & Welch, J. T. (2017) · ChemBioChem · doi:10.1002/cbic.201600655 · Cited by 15
Silica nanoparticle releases SIRT6-induced epigenetic silencing of follistatin
Zhang, L., Han, B., Xiang, J., Liu, K., Dong, H., & Gao, X. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.011 · Cited by 14
SIRT6 inhibits proliferation and invasion in osteosarcoma cells by targeting N‑cadherin
Gao, Y., Qu, Y., Zhou, Q., & Ma, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9676 · Cited by 15
Telomeric chromatin: Roles in aging, cancer and hereditary disease
McCord, R., & Broccoli, D. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.08.005 · Cited by 18
Self-citationSo, K.-Y., Park, B., & Oh, S. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09554-0 · Cited by 15
The possible role of sirtuins in male reproduction
Loganathan, C., Kannan, A., Panneerselvam, A., Mariajoseph-Antony, L. F., Kumar, S. A., Kumarasamy, A., & Prahalathan, C. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04116-2 · Cited by 14
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
Bajrami, I., Walker, C., Krastev, D. B., Weekes, D. B., Song, F., Wicks, A. J., Alexander, J. J., Haider, S. A., Brough, R., Pettitt, S. J., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02770-2 · Cited by 16
SIRT6 regulates endothelium-dependent relaxation by modulating nitric oxide synthase 3 (NOS3)
Wang, J., Liu, Z., Lü, J., Zou, J., Ye, W., Li, H., Gao, S., & Liu, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115439 · Cited by 14
SIRT6-PAI-1 axis is a promising therapeutic target in aging-related bone metabolic disruption
Aobulikasimu, A., Liu, T., Piao, J., Sato, S., Ochi, H., Okawa, A., Tsuji, K., & Asou, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-33297-7 · Cited by 14
The many faces of SIRT6 in the retina and retinal pigment epithelium
Cheng, J., Keuthan, C. J., & Esumi, N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1244765 · Cited by 14
SIRT-associated attenuation of cellular senescence in vascular wall
Sazdova, I., Hadzi‐Petrushev, N., Keremidarska‐Markova, M., Stojchevski, R., Sopi, R., Shileiko, S. A., Mitrokhin, V. M., Gagov, H., Avtanski, D. B., Lubomirov, L. T., et al. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111943 · Cited by 16
Marmisolle, I., Chacón, E., Mansilla, S., Ruiz, S., Bresque, M., Martínez, J., Martínez‐Zamudio, R. I., Herbig, U., Liu, J., Finkel, T., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103606 · Cited by 15
A new role for histone deacetylase 5 in the maintenance of long telomeres
Novo, C. L., Polese, C., Mathéus, N., Decottignies, A., Londoño‐Vallejo, A., Castronovo, V., & Mottet, D. (2013) · The FASEB Journal · doi:10.1096/fj.12-224204 · Cited by 14
Nucleosome organization and chromatin dynamics in telomeres
Ichikawa, Y., Nishimura, Y., Kurumizaka, H., & Shimizu, M. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2014-0035 · Cited by 14
Naciri, I., Laisné, M., Ferry, L., Bourmaud, M., Gupta, N., Carlo, S. E. D., Huna, A., Martin, N., Peduto, L., Bernard, D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz080 · Cited by 14
Tan, J. J., Wang, X., Hwang, B., Gonzales, R., Konen, O., Lan, L., & Lu, A.-L. (2020) · Aging · doi:10.18632/aging.103934 · Cited by 15
Zhu, W., Feng, D., Shi, X., Wei, Q., & Yang, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.850145 · Cited by 12
A FRET-based assay for screening SIRT6 modulators
Li, Y., You, L., Huang, W., Liu, J., Zhu, H., & He, B. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.008 · Cited by 14
Gesing, A., Masternak, M. M., Lewiñski, A., Karbownik‐Lewińska, M., Kopchick, J. J., & Bartke, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls231 · Cited by 14
Investigating the role of Sirtuins in cell reprogramming
Shin, J., Kim, J., Park, H., & Kim, J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.10.172 · Cited by 14
Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase
Dhillon, K. K., Sidorova, J. M., Albertson, T., Anderson, J. B., Ladiges, W., Rabinovitch, P. S., Preston, B. D., & Monnat, R. J. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.09.013 · Cited by 14
Sirtuin1 in vascular endothelial function, an overview
Kumar, J., & Kumar, S. (2021) · Epigenetics · doi:10.1080/15592294.2021.1975936 · Cited by 14
Astrocytic SIRT6 is a potential anti-depression and anti-anxiety target
Hu, K., Chen, H., Gao, Y., Hua, R., Shi, X., Li, L., Yin, Y., Zeng, C., Liu, Q., Qiu, Y., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110702 · Cited by 13
Aging, longevity, and the role of environmental stressors: a focus on wildfire smoke and air quality
Scieszka, D. P., Bolt, A. M., McCormick, M. A., Brigman, J. L., & Campen, M. J. (2023) · Frontiers in Toxicology · doi:10.3389/ftox.2023.1267667 · Cited by 15
Sharma, G., Banerjee, R., & Srivastava, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c07480 · Cited by 13
Froyd, C. A., Kapoor, S., Dietrich, F. S., & Rusché, L. N. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003935 · Cited by 13
A critical role of telomere chromatin compaction in ALT tumor cell growth
Shi, G. W., Hu, Y., Zhu, X. Q., Jiang, Y., Pang, J., Wang, C., Huang, W., Zhao, Y. B., Ma, W., Liu, D., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa224 · Cited by 14
Pascali, C., & Teichmann, M. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4525-4_12 · Cited by 14
Sirtuins in Aging and Age-Related Diseases
Haigis, M. C., & Sinclair, D. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00011-7 · Cited by 13
Hong, J., Mei, C., Li, S., Wang, H., Zhao, C., & Zan, L. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.09.018 · Cited by 13
Will the real aging Sirtuin please stand up?
Liao, C., & Kennedy, B. K. (2012) · Cell Research · doi:10.1038/cr.2012.62 · Cited by 13
Crosstalk between the DNA damage response, histone modifications and neovascularisation
Vassilopoulos, A., Deng, C., & Chavakis, T. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.020 · Cited by 12
Sirtuin 6 is a negative regulator of FcεRI signaling and anaphylactic responses
Jang, H., Ha, D. H., Rah, S., Lee, D.-H., Lee, S., & Park, B. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.012 · Cited by 12
Lee, Y., Kim, S., & Surh, Y. (2022) · Journal of Cancer Prevention · doi:10.15430/jcp.2022.27.3.157 · Cited by 12
Tyagi, W., & Das, S. (2024) · Science Advances · doi:10.1126/sciadv.ado7720 · Cited by 12
Increased chromatin accessibility underpins senescence
Lopes‐Paciencia, S., & Ferbeyre, G. (2025) · FEBS Journal · doi:10.1111/febs.70136 · Cited by 18
Zhang, Q., Liang, Z., Zhang, J., Lei, T., Dong, X., Su, H., Chen, Y., Zhang, Z., Tan, L., & Zhao, Y. X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.655552 · Cited by 14
A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis
Song, N., Tang, Y., Wang, Y., Guan, X., Yu, W., Jiang, T., Lu, L., & Gu, Y. (2023) · Marine Drugs · doi:10.3390/md21100517 · Cited by 12
The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging
Nahálková, J. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2836-5 · Cited by 13
Is SIRT6 Activity Neuroprotective and How Does It Differ from SIRT1 in This Regard?
Tang, B. L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00165 · Cited by 12
The Epigenetic Regulation of Telomere Maintenance in Aging
Shekhidem, H. A., & Atzmon, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811060-7.00005-x · Cited by 14
Proteomics of Long‐Lived Mammals
Tombline, G., Gigas, J., Macoretta, N., Zacher, M., Emmrich, S., Zhao, Y., Seluanov, A., & Gorbunova, V. A. (2019) · PROTEOMICS · doi:10.1002/pmic.201800416 · Cited by 12
Xie, X., Zhang, H., Gao, P., Wang, L., Zhang, A., Xie, S., & Li, J. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1435 · Cited by 11
Influences of histone deacetylase inhibitors and resveratrol on DNA repair and chromatin compaction
Keuser, B., Khobta, A., Gallé, K., Anderhub, S. J., Schulz, I., Pauly, K., & Epe, B. (2013) · Mutagenesis · doi:10.1093/mutage/get034 · Cited by 12
Sirtuins, Healthspan, and Longevity in Mammals
Giblin, W., & Lombard, D. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00003-4 · Cited by 12
Sequence Variants of SIRT6 Gene Promoter in Myocardial Infarction
Wang, L., Ma, L., Pang, S., Huang, J. A., & Yan, B. (2016) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2015.0188 · Cited by 12
Epigenetic Regulation by Dietary Restriction: Part II.
Ng, G. Y.-Q., Fann, D. Y., Jo, D., Sobey, C. G., & Arumugam, T. V. (2019) · PubMed · Cited by 12
Maldonado, M., Chen, J., Duan, H., Huang, T., Jiang, G., & Zhong, Y. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2021.02.001 · Cited by 11
Getting down to the core of histone modifications
Jack, A. P. M., & Hake, S. B. (2014) · Chromosoma · doi:10.1007/s00412-014-0465-x · Cited by 11
Chen, C., Xie, C., Xiong, Y., Wu, H., Wu, L., Zhu, J., Xing, C., & Mao, H. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.06.006 · Cited by 11
Li, J., Cao, Y., Niu, K., Qiu, J., Wang, H., You, Y., Li, D., Luo, Y., Zhu, Z., Zhang, Y., et al. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100276 · Cited by 12
Expression of SIRT2 and SIRT6 in Retinoblastoma
Orellana, M. E., Quezada-Ruiz, C., Maloney, S., Antecka, E., Balazsi, M., & Burnier, M. N. (2015) · Ophthalmic Research · doi:10.1159/000368718 · Cited by 11
Impacts on Sirtuin Function and Bioavailability of the Dietary Bioactive Compound Dihydrocoumarin
Jacobi, J. L., Yang, B. H., Li, X., Menze, A. K., Laurentz, S., Janle, E. M., Ferruzzi, M. G., McCabe, G. P., Chapple, C. C. S., & Kirchmaier, A. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149207 · Cited by 11
Molecular Mechanisms Mediating Adaptation to Exercise
Gholamnezhad, Z., Mégarbane, B., & Rezaee, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_3 · Cited by 12
Park, J. J., Hah, Y., Ryu, S., Cheon, S. Y., Won, S. J., Lee, J. S., Hwa, J. S., Seo, J., Chang, H. W., Kim, S. W., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00578-y · Cited by 11
Self-citationChimplee, S., Roytrakul, S., Sukrong, S., Srisawat, T., Graidist, P., & Kanokwiroon, K. (2022) · Molecules · doi:10.3390/molecules27020407 · Cited by 11
Ryu, J. S., & Koo, H. (2015) · Gerontology · doi:10.1159/000439200 · Cited by 11
Activation of SIRT6 Deacetylation by DNA Strand Breaks
Kang, W., Hamza, A., Curry, A. M., Korade, E., Donu, D., & Cen, Y. (2023) · ACS Omega · doi:10.1021/acsomega.3c04859 · Cited by 9
Skeletal phenotypes and molecular mechanisms in aging mice
Guan, Q., 上海体育大学运动健康学院, 上. 2., Zhang, Y., Wang, Z., Liu, X.-H., Zou, J., & Zhang, L.-L. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.397 · Cited by 13
A predictive chromatin architecture nexus regulates transcription and DNA damage repair
Bhat, A., Bhan, S., Kabiraj, A., PANDITA, R. K., Ramos, K. S., Nandi, S., Sopori, S., Sarkar, P. S., Dhar, A., Pandita, S., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108300 · Cited by 12
Binding to nucleosome poises human SIRT6 for histone H3 deacetylation
Smirnova, E., Bignon, E., Schultz, P., Pápai, G., & Shem, A. B. (2023) · eLife · doi:10.7554/elife.87989 · Cited by 21
Role of sirtuins in epigenetic regulation and aging control
Samoilova, E. M., Romanov, S. E., Chudakova, D. A., & Laktionov, P. P. (2024) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-24-26 · Cited by 10
Sirtuins and Cancer: New Insights and Cell Signaling
de Oliveira, M. V. M., Andrade, J. M. O., Paraíso, A. F., & Santos, S. H. S. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.853076 · Cited by 12
Transgenerational Inheritance of Longevity: Epigenetic Mysteries Abound
Berger, S. L. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.012 · Cited by 10
Faktor-Faktor Yang Berhubungan Dengan Terjadinya Fatigue Pada Pasien Hemodialisis
Maesaroh, M., Waluyo, A. D., & Jumaiyah, W. (2020) · Syntax Literate Jurnal Ilmiah Indonesia · doi:10.36418/syntax-literate.v5i4.1074 · Cited by 10
Sirtuin 6 promotes eosinophil differentiation by activating GATA‐1 transcription factor
Bang, I. H., Park, D., Lee, Y., Cho, H., Park, B., & Bae, E. J. (2021) · Aging Cell · doi:10.1111/acel.13418 · Cited by 9
Stem cell aging in adult progeria
Cheung, H., Pei, D., & Chan, W. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0021-z · Cited by 10
Guarding chromosomes from oxidative DNA damage to the very end
Tan, R., & Lan, L. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw040 · Cited by 10
Barbero, G., Serro, M. D. S., Lujan, C. P., Vitullo, A. D., González, C. R., & González, B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1086573 · Cited by 9
Enhancer-driven Shh signaling promotes glia-to-mesenchyme transition during bone repair
Shen, X., Zhang, H., Song, Z., Dong, Y., Ge, X., Jin, S., Guo, S., Zhang, P., Fu, Y., Zhu, Y., et al. (2025) · Bone Research · doi:10.1038/s41413-024-00396-8 · Cited by 11
Li, D., Li, W., Liao, X., Jiang, S., Ma, M., Hu, Z., Lin, K., Yu, W., Sun, X., Fan, Y., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08567-x · Cited by 11
Yuan, T., Keijer, J., Guo, A. H., Lombard, D. B., & de Boer, V. C. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-72833-7 · Cited by 9
Zhang, Q., Zhang, J., Lei, T., Liang, Z., Dong, X., Sun, L., & Zhao, Y. X. (2022) · Communications Biology · doi:10.1038/s42003-022-03484-9 · Cited by 9
Mahlknecht (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.872 · Cited by 9
du Preez, L. L., & Patterton, H. (2017) · Journal of Molecular Modeling · doi:10.1007/s00894-017-3308-x · Cited by 9
Sirtuins in Brain and Neurodegenerative Disease
Szegő, É. M., Outeiro, T. F., & Kazantsev, A. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813499-3.00013-7 · Cited by 9
Owczarz, M., Połosak, J., Domaszewska-Szostek, A., Kołodziej, P., Kuryłowicz, A., & Puzianowska‐Kuźnicka, M. (2020) · Epigenetics · doi:10.1080/15592294.2020.1780081 · Cited by 10
β-Cell-specific ablation of sirtuin 4 does not affect nutrient-stimulated insulin secretion in mice
Huynh, F. K., Peterson, B. S., Anderson, K. A., Lin, Z., Coakley, A. J., Llaguno, F. M. S., Nguyen, T.-T. N., Campbell, J. E., Stephens, S. B., Newgard, C. B., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00170.2020 · Cited by 9
Luo, S., Duan, K., Fang, C., Li, D., Zheng, S., Yang, S., Yang, S., Yang, M., Zhang, L.-B., & Wang, S. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s278248 · Cited by 10
Mammalian Sirtuins and Their Relevance in Vascular Calcification
Pan, X., Pi, C., Ruan, X., Zheng, H., Zhang, D., & Liu, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.907835 · Cited by 9
GB1a Activates SIRT6 to Regulate Lipid Metabolism in Mouse Primary Hepatocytes
Sun, Y., Zheng, C., Li, T., He, X., Yang, F., Guo, W., Song, J., Gao, Y., Deng, C., & Huang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119540 · Cited by 9
Divya, K. P., Kanwar, N., Anuranjana, P. V., Kumar, G., Beegum, F., George, K. T., Kumar, N., Nandakumar, K., & Kanwal, A. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09858-1 · Cited by 11
Suvarna, B. (2013) · Kathmandu University Medical Journal · doi:10.3126/kumj.v10i2.7350 · Cited by 8
Recent advances in understanding the role of lamins in health and disease
Reddy, S., & Comai, L. (2016) · F1000Research · doi:10.12688/f1000research.9260.1 · Cited by 9
Application of multivariate longitudinal models in SIRT6, FBS, and BMI analysis of the elderly
Gilani, N., Haghshenas, R., & Esmaeili, M. (2018) · The Aging Male · doi:10.1080/13685538.2018.1477933 · Cited by 9
Therapeutic Targets in Telomerase and Telomere Biology of Cancers
Prasad, R., Pal, D., & Mohammad, W. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00876-8 · Cited by 9
Zhu, G.-R., Zheng, X., Wang, Z., & Xu, X. (2022) · Biomolecules · doi:10.3390/biom12111655 · Cited by 8
Nahálková, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102496 · Cited by 9
SIRT5: a potential target for discovering bioactive natural products
Xie, Y., Cai, N., Liu, X., He, L., Ma, Y., Yan, C., Liang, J., Ouyang, S., Luo, A., He, Y., et al. (2025) · Journal of Natural Medicines · doi:10.1007/s11418-024-01871-6 · Cited by 10
Zhou, Y., Luo, Q., Gu, L., Tian, X., Zhao, Y., Zhang, Y., & Wang, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040563 · Cited by 9
Sirtuins in Parkinson's disease: Molecular mechanisms and pathophysiological roles
Li, X., Luo, X., Cao, X., Thomas, E. R., Wang, W., Zhou, X., Zhou, S., Wu, A., Gao, R., Liu, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102902 · Cited by 8
Insights into the therapeutic strategies for aging and aging-associated diseases
Dong, R., Wu, Q., Kan, J., Fu, C., Sorrentino, V., Chow, A., Lei, Y., Wu, D., Xu, Z., Du, J., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02662-z · Cited by 12
Elrashidy, R. A., Mohamed, H. E., Aal, S. M. A., Mohamed, S. R., Tolba, S. M., & Mahmoud, Y. K. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109986 · Cited by 8
Transcriptional, epigenetic and microRNA regulation of growth plate
Nakamichi, R., Kurimoto, R., Tabata, Y., & Asahara, H. (2020) · Bone · doi:10.1016/j.bone.2020.115434 · Cited by 9
C. eleganssirtuin SIR-2.4 and its mammalian homolog SIRT6 in stress response
Jedrusik, M. A. (2014) · Worm · doi:10.4161/worm.29102 · Cited by 7
Benech, P., & Patatian, A. (2014) · International Journal of Cosmetic Science · doi:10.1111/ics.12155 · Cited by 8
Histone Deacetylase Inhibitors in Cancer Prevention and Therapy
Movafagh, S., & Munson, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812494-9.00004-4 · Cited by 8
Metadata
- Authors
- Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L. A., Barrett, J. C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O., & Chua, K. F.
- Affiliations
- Stanford Medicine (US)
- VA Palo Alto Health Care System (US)
- Department of Biological Sciences (RU)
- National Institutes of Health (US)
- Corresponding author
- Chua, Katrin F.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7186
- Pages
- 492-496
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2646112
- OpenAlex
- W2029969982
- Semantic Scholar
- e93e298451cb0d965e8933da9a3ab04e44f65ff0
- Cited by
- 1,111
- References
- 32
- Citations by year
- 2026: 35 · 2025: 35 · 2024: 45 · 2023: 59 · 2022: 57 · 2021: 68 · 2020: 75 · 2019: 64 · 2018: 75 · 2017: 63 · 2016: 83 · 2015: 68 · 2014: 62 · 2013: 94 · 2012: 57
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (R01AG028867, K08AG028961)
- National Institute of General Medical Sciences (R01GM079641)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- SIRT6, telomeric chromatin, telomere maintenance, premature aging, Werner syndrome, WRN, cellular senescence, chromatin silencing, telomere dysfunction, NAD+-dependent deacetylation
- MeSH terms
- Werner Syndrome Helicase, Acetylation, Cell Line, Chromatin, DNA Replication, Exodeoxyribonucleases, Fibroblasts, Histone Deacetylases, Histones, Humans, Lysine, Phenotype, Protein Binding, Werner Syndrome, Telomere, Cellular Senescence, Telomerase, Sirtuins, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
